Alpha-difluoromethylornithine and polyamine levels in the human prostate: results of a phase IIa trial.
Simoneau
A R
AR
Veterans Administration Hospital, Long Beach, CA, USA.
Gerner
E W
EW
Phung
M
M
McLaren
C E
CE
Meyskens
F L
FL
D000970:Antineoplastic Agents / Q000378:metabolism* / Q000627:therapeutic use; D002851:Chromatography, High Pressure Liquid; D000518:Eflornithine / Q000378:metabolism* / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000378:metabolism* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011073:Polyamines / Q000378:metabolism*; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D011700:Putrescine / Q000378:metabolism; D013095:Spermidine / Q000378:metabolism; D013096:Spermine / Q000378:metabolism
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D011073:Polyamines; D013096:Spermine; D017430:Prostate-Specific Antigen; D013095:Spermidine; D011700:Putrescine; D000518:Eflornithine